- Home
- SCNX
as 12-23-2024 10:49am EST
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | LUTZ |
| Market Cap: | 59.2M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 13.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.69 - $44.56 | Next Earning Date: | 02-10-2025 |
| Revenue: | N/A | Revenue Growth: | 166.67% |
| Revenue Growth (this year): | 1085.75% | Revenue Growth (next year): | N/A |
Latest Scienture Holdings Inc. Common Stock News
SCNX Breaking Stock News: Dive into SCNX Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 days ago
Scienture Holdings, Inc. Announces Participation in The Microcap Conference 2025
GlobeNewswire
13 days ago
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
GlobeNewswire
a month ago
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement
Compare SCNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SCNX Scienture Holdings Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.